My watch list
my.chemeurope.com  
Login  

65 Current news about the topic research collaborations

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Solvay Pharmaceuticals signs research agreement

21-Feb-2003

Solvay Pharmaceuticals and Hormos Medical Corporation (Finland) have signed a research collaboration and license agreement in the women's health therapeutic area. The agreement comprises a collaborative discovery programme, initially until January 2006 with possible extension beyond that. The ...

more

AMRI Announces Natural Products Research Collaboration with Eli Lilly and Company

13-Feb-2003

Albany Molecular Research, Inc. (Nasdaq: AMRI) has entered into a three-year natural products research collaboration focused on screening and lead identification with Eli Lilly and Company (Lilly). The goal of the collaboration is to discover and develop potential therapeutic agents for ...

more

CareX and Chemical Diversity Labs announce research agreement

23-Oct-2002

French biopharmaceutical company CareX S.A. and San Diego based Chemical Diversity Labs, Inc. announced that they have formed a research collaboration that applies methods of rational drug design to Focused Library Screening of bio-active substances. Under the terms of the agreement, Chemical ...

more

4SC and Schering Sign Research Collaboration for The Identification of Novel Drug Candidates

11-Oct-2002

MARTINSRIED, Germany, Oct. 8 - 4SC AG announced today the signing of a research collaboration with Schering AG to identify novel molecules, that bind to a specific undisclosed target provided by Schering, to serve as the basis for drug discovery. Under the terms of the agreement, 4SC will use its ...

more

DSM and Avantium announce research collaboration in high throughput experimentation for life science products

05-Feb-2002

4 February 2002 - DSM and Avantium Technologies announced that they have entered into a cooperation agreement to discover new and improved catalytic systems relevant to DSM's life sciences business. Avantium will conduct services relating to high throughput experimentation and simulation methods ...

more

Neurogen and Aventis Pharma announce worldwide collaboration

27-Dec-2001

Neurogen Corp and Aventis Pharma have jointly announced an exclusive worldwide collaboration to develop new drugs for treatment of depression, anxiety, and other stress-related disorders based on Neurogen's innovative portfolio of pre-clinical corticotrophin releasing factor (CRF1) antagonist ...

more

Boehringer Ingelheim and Structural Bioinformatics, Inc. agree on research collaboration involving new anti-HIV compound/leads

18-Dec-2001

Boehringer Ingelheim (Canada) Ltd. and Structural Bioinformatics, Inc. (SBI) have agreed on a research collaboration to use SBI?s Variome? database for Boehringer Ingelheim?s in silico drug discovery of HIV protein targets. Variome? is a structural pharmacogenomics database consisting of more ...

more

Bayer starts research collaboration with Italian biotech company in the field of post-genomics

Bayer's Italian research unit to be integrated into newly founded biotech company Axxam

19-Nov-2001

Leverkusen – Bayer has entered a collaboration with Axxam S.r.l., a newly formed Italian biotechnology company, in the field of post-genomics with the objective of developing several technology platforms for modern drug discovery. The results of genome research are thus used to develop biological ...

more

Tularik Receives Milestone Payment From Eli Lilly And Company

09-Nov-2001

Tularik Inc. (Nasdaq: TLRK) today announced that its anti-thrombotic research collaboration with Eli Lilly and Company (NYSE: LLY) has successfully progressed to an advanced stage of preclinical development, triggering an undisclosed milestone payment to Tularik. As part of the July ...

more

Lilly and Isis Pharmaceuticals Announce Strategic Alliance

23-Aug-2001

Eli Lilly and Company (NYSE: LLY) and Isis Pharmaceuticals, Inc. (NASDAQ: ISIP) announced today that they have entered into a strategic alliance that includes the license of Isis' novel antisense cancer compound and the formation of a broad collaboration to discover antisense drugs. The ...

more

Page 5 From 7
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE